John H Abeles's Net Worth
$45.3 Thousand
Who is John H Abeles?
John H Abeles does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CombiMatrix Corp, Neurotrope, Inc., DUSA PHARMACEUTICALS INC, Medite Cancer Diagnostics, Inc., ORYX TECHNOLOGY CORP, ENCORE MEDICAL CORP, and I FLOW CORP /DE/.
SEC CIK
John H Abeles's CIK is 0000902418
Past Insider Trading and Trends
2015 was John H Abeles's most active year for acquiring shares with 6 total transactions. John H Abeles's most active month to acquire stocks was the month of December. 2005 was John H Abeles's most active year for disposing of shares, totalling 3 transactions. John H Abeles's most active month to dispose stocks was the month of December. 2005 saw John H Abeles paying a total of $94,475.00 for 40,000 shares, this is the most they've acquired in one year. In 2005 John H Abeles cashed out on 30,000 shares for a total of $150,030.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CombiMatrix Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 9.12K |
—
|
—
| 9.12K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Neurotrope, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
DUSA PHARMACEUTICALS INC No price found
InvestorJohn H Abeles owns 12,500 units of Common Stock. From 2006 to 2010 John H Abeles acquired a total of 32,500 shares in DUSA PHARMACEUTICALS INC at a cost of $104,725.00, John also disposed a total of 10,000 shares of DUSA PHARMACEUTICALS INC equalling to $150,030.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +108.11% | 40K |
$1.28 | $51,080.00 | 77K |
Dec 16 - Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +150.00% | 7.5K |
—
|
—
| 12.5K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +4.57% | 5K |
$2.05 | $10,250.00 | 114.5K |
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
∞
| 10K |
$9.86 | -$55,555.00 | 10K |
Jan 19 - Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +68.97% | 10K |
$2.90 | $29,000.00 | 24.5K |
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Medite Cancer Diagnostics, Inc. No price found
InvestorJohn H Abeles owns 10,000 units of Common Stock, $.001 par. From 2006 to 2018 John H Abeles acquired a total of 10,000 shares in Medite Cancer Diagnostics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.34% | 306.67K |
$0.08 |
—
| 1.57M |
Aug 13 - Oct 11
| |||
Form 4
| +18.11% | 400K |
$0.08 | $30,000.00 | 2.61M |
Jul 3
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
No matching records found |
ORYX TECHNOLOGY CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4K |
$1.63 | $6,510.00 | 2.46K |
Dec 6
| |||
Form 4
| +9.58% | 7.28K |
$1.50 | $10,917.00 | 83.22K |
Jul 22
| |||
Form 4
| +35.75% | 20K |
$2.50 | $50,000.00 | 75.94K |
Jan 29
| |||
Form 4
|
∞
| 20K |
$1.00 | $20,000.00 | 20K |
Jul 28
| |||
No matching records found |